Bristol-Myers sues immunotherapy exec who left for AstraZeneca
May 29, 2015 at 14:57 PM EDT
NEW YORK, May 29 (Reuters) - Bristol-Myers Squibb has sued a top cancer immunotherapy executive for violating confidentiality and non-compete agreements after he left for direct competitor AstraZeneca, court documents show.
